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Retinoic acid signalingAn epithelial sheet, the epicardium, lines the surface of the heart. In the developing embryo, the epicardium
expresses the transcriptional regulator Wilm's Tumor Gene 1 (Wt1). Through incompletely understood
mechanisms, Wt1 inactivation derails normal heart development. We investigated mechanisms by which Wt1
regulates heart development and epicardial epithelial tomesenchymal transition (EMT).Weusedgenetic lineage
tracing approaches to track and isolate epicardium and epicardium derivatives in hearts lacking Wt1 (Wt1KO).
Wt1KO hearts had diminished proliferation of compact myocardium and impaired coronary plexus formation.
Wt1KOepicardium failed to undergoEMT.Wt1KO epicardiumexpressed reduced Lef1 and Ctnnb1 (β-catenin), key
components of the canonicalWnt/β-catenin signaling pathway.Wt1KO epicardiumexpressed decreased levels of
canonicalWnt downstream targets Axin2, Cyclin D1, and Cyclin D2 and exhibited decreased activity of the Batgal
Wnt/β-catenin reporter transgene, suggestive of diminished canonical Wnt signaling. Hearts with epicardium-
restricted Ctnnb1 loss of function resembled Wt1KO hearts and also failed to undergo epicardial EMT. However,
Ctnnb1 inactivation did not alter WT1 expression, positioning Wt1 upstream of canonical Wnt/β-catenin
signaling. Wnt5a, a prototypic non-canonical Wnt with enriched epicardial expression, and Raldh2, a key
regulator of retinoic acid signaling conﬁned to the epicardium, were also markedly downregulated in Wt1KO
epicardium. Hearts lacking Wnt5a or Raldh2 shared phenotypic features with Wt1KO. Although Wt1 has been
proposed to regulate EMT by repressing E-cadherin, we detected no change in E-cadherin inWt1KO epicardium.
Collectively, our study shows thatWt1 regulates epicardial EMT and heart development through canonicalWnt,
non-canonical Wnt, and retinoic acid signaling pathways.ransition; EPDC, Epicardium-
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Amesothelial sheet of cells, the epicardium, covers the surface of the
heart. Epicardium participates in heart development by engaging in
reciprocal signaling with the subjacent tissue, and by forming
mesenchymal cells through epithelial to mesenchymal transition
(EMT) (Wilm et al., 2005; Winter and Gittenberger-de Groot, 2007).
Thesemesenchymal cells contribute to cardiomyocytes, smoothmuscle,
ﬁbroblast, and endothelial lineages of the developing heart (Cai et al.,2008; Merki et al., 2005;Wilm et al., 2005; Zhou et al., 2008). Epicardial
inhibition in avian embryos and epicardial gene disruption in murine
embryos have demonstrated that epicardium is required for normal
myocardial and coronary vessel development (Gittenberger-de Groot
et al., 2000; Kwee et al., 1995; Lavine et al., 2006; Lin et al., 2010; Merki
et al., 2005; Yang et al., 1995; Zamora et al., 2007).
The molecular regulation of epicardial function is just beginning to
be investigated. The transcriptional regulator Wilm's tumor gene 1
(Wt1) is expressed in epicardium, as well as in other mesothelia and
the developing genitourinary system (Moore et al., 1998). Deletion of
Wt1 caused abnormal development of multiple organs, including the
heart (Ijpenberg et al., 2007; Kreidberg et al., 1993; Moore et al.,
1999). In the developing heart, Wt1 expression is conﬁned to the
epicardium (Moore et al., 1999; Zhou et al., 2008). Loss ofWt1 caused
embryonic lethality, peripheral edema, pericardial hemorrhage, and
thinning of the myocardial wall (Kreidberg et al., 1993; Martinez-
Estrada et al., 2010; Moore et al., 1999). However, the molecular
mechanisms underlying this phenotype are not well understood.
422 A. von Gise et al. / Developmental Biology 356 (2011) 421–431In this study we investigated the effect of Wt1 loss of function on
epicardium function in the developing heart, focusing on the effect of
Wt1 deﬁciency on the formation of epicardium-derived cells (EPDCs)
by epicardial EMT. We found that Wt1 is required for epicardial EMT,
acting upstream of canonical Wnt, non-canonical Wnt, and retinoic
acid signaling pathways.
Materials and methods
An expanded Methods section is available in the Online Data
Supplement.
Mice
Wt1GFPCre (Zhou et al., 2008), Wt1CreERT2 (Zhou et al., 2008),
Rosa26mTmG (Muzumdar et al., 2007), Wnt5anull (Yamaguchi et al.,
1999), Batgal (Maretto et al., 2003), and Ctnnb1ﬂox (Brault et al., 2001)
alleles have been previously described, and mice are available from
Jackson Laboratories (stock numbers 010911, 010912, 007676, 004758,
005317, and 004152, respectively). Mice were on a mixed genetic
background. Epicardial cells were puriﬁed by dissociation of fetal hearts
and FACS sorting, as described previously (Zhou et al., 2010). Tamoxifen
was suspended in sunﬂower seed oil at 12 mg/ml by sonication.
0.12 mg/g body weight tamoxifen was administered to pregnant dams
by gavage at E10.5. All-trans retinoic acid (ATRA; 2.5 μg/g body weight)
was given to pregnant females by gavage from E10.5 to E13.5. All
procedures involving mice were performed following protocols ap-
proved by the Institutional Animal Care and Use Committee.
Gene expression
RNA was isolated using the RNeasy Micro kit (Qiagen), reverse
transcribed using Superscript III, and quantitated by qRTPCR with Sybr
green chemistry on an ABI7300 real time PCR system. Relative gene
expression was calculated using the ΔΔCt method and normalized to
Gapdh. For linear RNA ampliﬁcation and conversion to cDNA, we used
the Ovation PicoSL WTA system (NuGen). Primer sequences are
provided in Suppl. Table 1.
Immunohistochemistry
Sections were stained with primary antibodies listed in Suppl. Table
2 and detected with Alexa Fluor conjugated secondary antibodies
(Invitrogen). Nuclei were counterstained with DAPI. In some cases,
signal ampliﬁcation was performed using secondary antibodies conju-
gated to multimerized horse radish peroxidase (SuperPicture, Invitro-
gen) followed by incubation with tyramide-Cy3 or tyramide-Cy5
(PerkinElmer). Where necessary, tissue GFP and RFP ﬂuorescence
fromtheRosa26mTmGallelewere bleachedby treatmentwith3%H2O2 in
methanol and illumination on a ﬂuorescent light box from 4 h to
overnight at 4 °C. Images were acquired on a Fluoview F1000 confocal
microscope (Olympus). Unless otherwise noted, images are represen-
tative of at least eightﬁelds from each of at least three separate embryos
per group.
Statistics
Values are reported as mean±SEM. The t-test was used to test for
statistical signiﬁcance between groups.
Results
Wt1 knockout cardiac phenotype
We previously generatedWt1CreERT2 andWt1GFPCre knockin alleles
(Zhou et al., 2008). In addition to expressing CreERT2 or GFPCre fusionproteins under control of Wt1 regulatory elements, these alleles are
protein null for WT1, as demonstrated by immunohistochemistry of
Wt1CreERT2/GFPCre embryos (Suppl. Fig. 1). Wt1 knockout (Wt1KO)
embryos died at E13.5 to E14.5, and no embryos survived to birth.
E13.5 embryos showed remarkable hydrops fetalis, with cutaneous
edema and an obvious pericardial effusion (Figs. 1A–B and E–F). The
hearts of Wt1KO embryos were smaller, appeared developmentally
delayed, and exhibited a biﬁd apex of varying severity (Figs. 1C and
G). Histological sections showed that Wt1KO hearts were four
chambered and had normal atrio-ventricular and ventriculo-arterial
connections. However, as previously noted the myocardial wall was
moderately thinned and the superior cardinal veins developed
abnormally (Figs. 1D, H, and I and data not shown) (Moore et al.,
1999; Norden et al., 2010). Decreased cardiomyocyte proliferation
contributed to the myocardial hypoplasia, as phosphorylated histone
H3 staining showed reduced proliferation in Wt1KO hearts compared
to littermate controls (Fig. 1J).
Consistent with previous reports (Martinez-Estrada et al., 2010;
Wagner et al., 2005), Wt1KO hearts exhibited markedly impaired
coronary vascular development (Figs. 1K–L). Although most coronary
endothelial cells do not derive from Wt1-marked epicardial pro-
genitors (Wilm et al., 2005; Zhou et al., 2008), the coronary vascular
plexus develops immediately subjacent to the epicardium, and
epicardium is a rich source of angiogenic paracrine factors (Zhou
et al., 2011). We hypothesized that impaired expression of angiogenic
paracrine factors contributes to the observed coronary vascular defect
of Wt1-deﬁcient embryos. To test this hypothesis, we isolated Wt1-
expressing epicardial cells from E13.5 Wt1GFPCre/GFPCre or Wt1GFPCre/+
hearts by ﬂuorescence activated cell sorting (FACS) for GFP (Fig. 2A).
This population, which we named EPI, contained primarily epicardial
cells, plus the subset of EPDCs that transiently continue to express
Wt1 or are marked as a result of perdurance of GFP. Each fetal heart
yielded approximately 2000 EPI cells, from which we puriﬁed
approximately 5 ng total RNA. After reverse transcription and linear
RNA ampliﬁcation, we measured gene expression by quantitative
RTPCR (qRTPCR). InWt1GFPCre/+ hearts, EPI cells were highly enriched
for epicardial markers Wt1 and Raldh2 compared to non-epicardial
cells (Fig. 2B), validating the purity of the FACS-sorted cells. Next, we
compared gene expression between control and mutant hearts. Wt1
was robustly detected in control EPI cells and markedly downregulated
inWt1KO,while expression of the epicardial genemesothelin (Msln) did
not differ between control and Wt1KO (Fig. 2C). These data provide
technical validation of our ability to detect gene expression differences
between control and mutant genotypes. We then measured EPI
expression of angiogenic paracrine factors. Vegfa and Angpt1 were
signiﬁcantly downregulated in Wt1KO, while expression of other
angiogenic factors such as Fgf2 were unchanged (Fig. 2D). Together,
these data suggest that deﬁcient epicardial expression of angiogenic
factors such asVegfa and Angpt1 contribute to abnormal coronary vessel
development in Wt1KO heart.
Wt1 is required for normal epicardial EMT
Loss of Wt1 was previously shown to reduce the subepicardial
mesenchyme, indirectly suggesting impaired epicardial EMT (Moore
et al., 1999). We previously usedWt1CreERT2/+ to show by genetic fate
mapping that epicardial cells undergo EMT to generate mesenchymal
cells that migrate into the myocardium (Zhou et al., 2008, 2010). To
directly test the hypothesis that Wt1 is required for epicardial EMT,
we used this genetic lineage tracing system to identify epicardium
derived mesenchymal cells (EPDCs) in the Wt1 null background. The
Cre-activated reporter, Rosa26mTmG, expresses membrane localized
red ﬂuorescent protein (mRFP) prior to recombination, and mem-
brane localized GFP (mGFP) following Cre recombination (Muzumdar
et al., 2007). We induced recombination in Wt1CreERT2/CreERT2
Rosa26mTmG (knockout) and Wt1CreERT2/+ Rosa26mTmG (control)
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Fig. 1. Phenotype of E13.5 Wt1KO embryos. A–H. Compared to control (Wt1+/−; A–D), Wt1KO (E–H) embryos displayed body wall edema (white arrows) and a pronounced
pericardial effusion, evident on backlighting by a translucent chest cavity (black arrows) in which the cardiac silhouette was clearly visible. Wt1KO hearts were smaller, with more
rounded and biﬁd apices (arrowheads). Ventricular myocardiumwas thinned. I. Thinning ofWt1KO compact myocardium, marked by dashed lines. Pecam staining (red) highlighted
the endocardial margin of the compact myocardium. J. Reduced proliferation of cardiomyocytes (CM) in Wt1KO, as indicated by pH3 staining. Arrowheads, pH3+ CM nuclei.
K. Deﬁcient coronary vessel development in Wt1KO, by whole mount Pecam staining. L. Quantitation of K. Coronary coverage was measured as the projected fraction of the dorsal
surface of the ventricles covered by a vascular network. *, Pb0.05. Scale bars 1 mm (yellow), 100 μm (other).
423A. von Gise et al. / Developmental Biology 356 (2011) 421–431embryos by treating with one dose of tamoxifen (Tam) at E10.5, a
time point when Wt1 expression in the heart is restricted to the
epicardium (Zhou et al., 2008). In control embryos, this induction
protocol labeled epicardium (arrowheads, Fig. 3A), as well as EPDCs
within the myocardium (arrows, Fig. 3A). In Wt1 knockout embryos,
epicardium was labeled and covered most areas of the heart
(arrowheads, Fig. 3B), although there were patchy areas lacking
epicardium as noted previously (Moore et al., 1999). GFP+ cells were
not observed within the Wt1KO myocardium, indicating that Wt1 is
required for formation of EPDCs from epicardium by EMT.
In addition to epicardium,Wt1marksmesothelium overlyingmost
visceral organs, including gut mesothelium (Wilm et al., 2005). Gut
mesothelium also undergoes EMT, forming smooth muscle cells that
contribute to the gut vasculature (Wilm et al., 2005). Tam pulse atE10.5 of Wt1CreERT2/+ Rosa26mTmG embryos labeled gut mesenchymal
cells (Fig. 3C), conﬁrming their origin from gut mesothelium. In
littermate Tam-pulsed, Wt1-deﬁcient Wt1CreERT2/CreERT2 Rosa26mTmG
embryos, we continued to observe robust formation and labeling of
gut mesenchymal cells (Fig. 3D). These data suggest that Wt1 is
required for EMT in some but not all mesothelia.
The transcription factors SNAI1 (also known as SNAIL) and SNAI2
(SLUG) regulate EMT by repressing the intercellular adhesion
molecule CDH1 (E-cadherin) (Thiery and Sleeman, 2006). Recently,
deﬁcient EMT in Wt1 knockout embryos was proposed to be due to
downregulation of SNAIL and SLUG and consequent ectopic expres-
sion of E-cadherin in epicardial cells (Martinez-Estrada et al., 2010).
We investigated putative upregulation of epicardial E-cadherin as a
mechanism for impaired EMT in Wt1KO heart. We were not able to
GFP+ (EPI)
GFP- non-EPI
FACS
A B
C
Wt1GFPCre/+
Si
de
 S
ca
tte
r
GFP intensity
1.68%
EPI
Wt1GFPCre/+Wt1+/+
R
el
at
iv
e 
Ex
pr
0.0
0.5
1.0
1.5
R
el
at
iv
e 
Ex
pr
**
EPI non-EPI
0
5
15
20
25
*
10
0
10
20
30
40
Raldh2
*
Wt1
Wt1 Msln
0
1.0
2.0
R
el
at
iv
e 
Ex
pr
an
g
an
gp
t1
an
gp
t2 fgf
1
fgf
2
ve
gfa
Ctrl CtrlWt1KO Wt1KOD
* *
Fig. 2. FACS isolation of Wt1KO and control epicardial cells and measurement of epicardial expression of angiogenic factors. A. FACS isolation of WT1-expressing cells by GFP
ﬂuorescence from Wt1GFPCre ventricular apex. The GFP+ population was named EPI. B. Quantitative RTPCR (qRTPCR) of EPI and non-EPI populations showed strong enrichment of
epicardial marker genes in Wt1GFPCre/+ hearts. C. Wt1 but not Msln was strongly downregulated in Wt1GFPCre/GFPCre (KO) compared to Wt1GFPCre/+ (Ctrl) in the EPI population.
D. Downregulation of Vegfa and Angpt1 in Wt1KO epicardium. *, Pb0.05. **, Pb0.01. N=4–5 per group.
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Fig. 3.Defective mesothelial EMT inWt1KO heart but not gut. A–B. Cryosections of E13.5 control andWt1KO hearts. Wt1CreERT2, activated by Tam at E10.5, efﬁciently labeled epicardial
cells (arrowheads). The membrane-localized GFP genetic lineage tracer demonstrated epicardium-derived EPDCs (arrows) within control but not Wt1KO myocardium. Insets show
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epicardium (Suppl. Fig. 2A). Meanwhile, E-cadherin was robustly
detected in bronchial epithelium in both groups (Suppl. Fig. 2A),
excluding technical failure of E-cadherin staining. These data indicate
that proposed upregulation of E-cadherin in Wt1KO does not account
for the EMT defect. We also investigated expression of SNAIL and
SLUG. In control embryos, SNAIL and SLUG were expressed in a subset
of subepicardial mesenchyme rather than in epicardium itself,
suggesting activation of SNAIL and SLUG in these cells soon after
undergoing epithelial to mesenchymal transition (Suppl. Figs. 2B–C).
InWt1 knockout epicardium, subepicardial cells continued to stain for
SNAIL and SLUG, although the number of these cells was decreased
(Suppl. Figs. 2B–C). As an internal staining control, SNAIL and SLUG
were detected in endocardial cushions as previously reported
(Niessen et al., 2008).
To evaluate Snail, Slug, and E-cadherin expression downstream of
Wt1 using amore objective and quantitative approach,we used qRTPCR
to measure transcript levels in the FACS-puriﬁed EPI population. E-
cadherin transcript was undetectable in either control or Wt1KO EPI,
supporting our immunostaining data. Snail and Slug were reduced or
tended to be reduced in Wt1KO (Pb0.05 and P=0.12, respectively;
Suppl. Fig. 2D), consistent with the reduced number of subepicardial
mesenchymal cells seen by immunostaining (Suppl. Figs. 2B–C).
The qRTPCR and immunostaining data together indicate Snail, Slug, or
E-cadherin are unlikely to be direct downstream targets of Wt1 within
the epicardium that linkWt1 loss of function with deﬁcient EMT.
Wt1 promotes epicardial β-catenin signaling
β-Catenin signaling is an important regulator of EMT (Thiery and
Sleeman, 2006). Recently, it was reported that inactivation of ﬂoxed
Ctnnb1 (β-catenin) with Gata5-Cre, whose recombination domain
includes the epicardium, resulted in a cardiac phenotype similar to
Wt1KO, including abnormal coronary vessel development and im-
paired expansion of the subepicardial mesenchyme suggestive of
deﬁcient epicardial EMT (Zamora et al., 2007). These data suggested
an essential role ofWnt signaling in epicardial EMT. However, because
of the multiple functions of β-catenin in cellular adhesion as well as
Wnt signaling, the role of Wnt signaling in this process remained
unclear. To gain further insights into the role of Wnt signaling in
epicardial EMT, we used genetic lineage tracing to identify EPDCs in
explant cultures treated with DKK1 or soluble frizzled 1 or 2 (sFRP1 or
sFRP2), inhibitors of canonical Wnt signaling. In control explants,
GFP+ EPDCs were observed in the subepicardial region and migrating
into the myocardium. While sFRP1 did not consistently affect
epicardial EMT, DKK1 or sFRP2 treatment abrogated GFP+ EPDCs in
the subepicardial region and within the myocardium (Fig. 4A). These
data indicate that Wnt signaling is required for epicardial EMT.
To evaluate whether or not Wnt/β-catenin signaling is down-
stream of Wt1, we used qRTPCR to measure expression of genes
involved in this signaling pathway in FACS-puriﬁedWt1KO EPI. Key β-
catenin signaling pathway components Lef1 and Ctnnb1 were down-
regulated in Wt1KO (Pb0.05; Fig. 4B). The Wnt inhibitor Sfrp2 tended
to be upregulated but this did not reach statistical signiﬁcance
(Fig. 4B). We further conﬁrmed CTNNB1 downregulation at the
protein level by immunostaining (Fig. 4C). In control hearts, CTNNB1
was detected in both myocardium and epicardium. In Wt1KO hearts,
CTNNB1 expression in myocardium was preserved, but expression in
epicardium was diminished (Fig. 4C). CTNNB1 activity is modulated
by phosphorylation of Ser37 and Thr41, which promote its degrada-
tion, and Ser675, which enhances its nuclear accumulation and
transcriptional activity. Thus, modiﬁcation speciﬁc antibodies to non-
phosphorylated Ser37/Thr41 or phosphorylated Ser675 detect acti-
vated subsets of CTNNB1. Immunoreactivity to these modiﬁcation
speciﬁc antibodies was likewise reduced in Wt1KO (Fig. 4C), consis-
tent with an overall decrease in CTNNB1 levels and lack of enhancedactivation of CTNNB1 that might compensate for decreased overall
levels.
Downregulation of Ctnnb1 and Lef1 transcripts in Wt1KO epicar-
dium indicated thatWt1 regulates canonical Wnt signaling. To further
test this hypothesis, we asked if transcripts of downstream targets of
canonical Wnt signaling were decreased in FACS-puriﬁed Wt1KO EPI
cells. Indeed, the typical Wnt downstream targets Axin2, Ccnd1 (Cyclin
D1), and Ccnd2 (Cyclin D2) (Jho et al., 2002; Megason and McMahon,
2002) were downregulated in Wt1KO EPI (Fig. 4D), consistent with
decreased CTNNB1/LEF1 signaling. Moreover, activity of the Batgal
transgene reporter of Wnt/β-catenin signaling (Maretto et al., 2003)
was decreased in Wt1KO epicardium compared to control (Fig. 4E).
Ctnnb1was previously inactivated in the Gata5-Cre recombination
domain (Zamora et al., 2007), which includes epicardium and
additional domains within the heart. The timing and tissue distribu-
tion of recombination differs from that catalyzed by Wt1CreERT2
embryos induced by Tam treatment at E10.5. To further analyze the
function of Ctnnb1 in epicardium, we treated Ctnnb1ﬂox/ﬂox
Wt1CreERT2/+ embryos with Tam at E10.5. These embryos, referred
to as Ctnnb1EPI, exhibited selective loss of CTNNB1 immunoreactivity
in the epicardium at E13.5, conﬁrming epicardium-restricted loss of
function and also conﬁrming speciﬁcity of CTNNB1 immunostaining
(Fig. 5A). Ctnnb1EPI embryos had peripheral edema like Wt1KO, but
lacked pericardial effusion (Fig. 5B). As in Wt1KO, E-cadherin
immunoreactivity was not detected in Ctnnb1EPI or control embryos
(Suppl. Fig. 3). Examination of the Cre-activated GFP genetic lineage
tracer conﬁrmed markedly reduced epicardial EMT compared to
heterozygous Ctnnb1ﬂox/+ Wt1CreERT2/+ controls (Fig. 5C). We noted
that control Ctnnb1ﬂox/+ Wt1CreERT2/+ hearts, heterozygous for both
Wt1 and Ctnnb1 in epicardium, had less GFP+ EPDCs compared to
Ctnnb1+/+ Wt1CreERT2/+ hearts (Fig. 3A vs. Fig. 5C). We conﬁrmed
this observation by quantitating GFP+ EPDCs (P=0.03; Suppl. Fig. 4).
This difference suggested genetic interaction between Wt1 and
Ctnnb1 in epicardium, consistent with WT1 and CTNNB1 function in
the same pathway (see Discussion). WT1 immunoreactivity was
unchanged in Ctnnb1EPI compared to controls, demonstrating that
epicardium formation was intact in the absence of Ctnnb1 (Fig. 5D).
Moreover, this result positioned Ctnnb1 downstream and not
upstream of Wt1. Overall, these data indicate that downregulation
of CTNNB1 downstream of Wt1 contributes to the Wt1KO phenotype.
In addition to canonical Wnt signaling through CTNNB1/LEF1, Wnt
signaling also proceeds through non-canonical pathways. WNT5A is a
prototypical non-canonical Wnt ligand. In situ hybridization demon-
strated epicardial enrichment of Wnt5a (Visel et al., 2004) (www.
genepaint.org; Suppl. Fig. 5), and this was conﬁrmed by qRTPCR of
FACS-puriﬁed EPI cells (Fig. 6A). Wnt5a was previously implicated as
an epicardial factor that promoted compact myocardial growth
(Fraidenraich et al., 2004). In the Wt1KO FACS-puriﬁed EPI population,
Wnt5a expressionwas reduced (Pb0.05; Fig. 6B), indicating thatWnt5a
is downstream of Wt1. Wnt5a knockout embryos were reported to die
perinatally from outﬂow tract abnormalities (Schleiffarth et al., 2007).
However, other defects in cardiac development in Wnt5a−/− embryos
were not previously examined. We found that Wnt5a−/− hearts, like
Wt1KOhearts, developed thinningof the compactmyocardium(Fig. 6C),
suggesting that Wnt5a downregulation in Wt1KO epicardium contrib-
utes to the mutant phenotype. WT1 expression was unchanged in
Wnt5a−/− heart, indicating that Wt1 is genetically upstream and not
downstream of Wnt5a (Fig. 6D). Likewise, CTNNB1 immunoreactivity
was unchanged in Wnt5a−/− (Fig. 6D).
Wt1 is required for normal epicardial expression of RALDH2
Retinoic acid signals are crucial for cardiac patterning and morpho-
genesis (Chen et al., 2002; Hochgreb et al., 2003; Lin et al., 2010;
Stuckmannet al., 2003). Cardiac expressionof RALDH2, the rate-limiting
enzyme in retinoic acid synthesis, is conﬁned to the epicardium (Moss
426 A. von Gise et al. / Developmental Biology 356 (2011) 421–431et al., 1998). Measurement of Raldh2 expression in FACS-puriﬁed EPI
cells by qRTPCR showed that it is markedly downregulated in Wt1KO
(Fig. 7A). To further validate downregulation of RALDH2 protein in
Wt1KO epicardium, we performed RALDH2 immunohistochemistry.A
C
D ERALDH2 was markedly downregulated in Wt1KO epicardium (Fig. 7B,
blue arrowheads). Intriguingly, RALDH2 expression in mesothelium
overlying the lung was not altered (Fig. 7B, green arrowheads),
suggesting that regulation of RALDH2 is distinct in different subtypesB
AB
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D
Fig. 5.Wnt/β-catenin signaling is downstream ofWt1. A. Loss of epicardial CTNNB1 immunoreactivity (arrows) in E13.5 Ctnnb1EPI (Ctnnb1ﬂox/ﬂox Wt1CreERT2/+) epicardium. B. Gross
morphology of E13.5 Ctnnb1EPI and control embryos and hearts. Arrows indicate peripheral edema. No pericardial effusion was evident. C. Deﬁcient epicardial EMT in E13.5
Ctnnb1EPI. GFP+ epicardium-derived cells (arrowheads) were present within the myocardium of control (Ctnnb1ﬂ/+ Wt1CreERT2/+) but not mutant hearts. D. WT1 expression was
not signiﬁcantly changed in E13.5 Ctnnb1EPI compared to control heart. Scale bars: 1 mm (blue), 100 μm (white), 10 μm (yellow).
427A. von Gise et al. / Developmental Biology 356 (2011) 421–431of mesothelium. Epicardium, marked by GFP in Wt1CreERT2/+
Rosa26mTmG embryos, was intact in regions with diminished RALDH2
immunoreactivity, excluding loss of epicardial cells as the cause
(Fig. 7C). In contrast to Wt1KO embryos, Ctnnb1EPI and Wnt5a−/−
hearts expressed RALDH2 normally (Figs. 7D and 6D), indicating that
Raldh2 is downstream ofWt1 but not β-catenin orWnt5a. Furthermore,Fig. 4. Downregulation of Wnt/β-catenin signaling components in Wt1 loss of function. A. W
and cultured in the presence of the indicated inhibitor of canonical Wnt signaling. DKK1 a
Wnt/β-catenin signaling components inWt1KO (Wt1GFPCre/GFPCre) compared to Ctrl (Wt1GFPC
RNA, n=10–12. Other genes were measured with ampliﬁed RNA, n=4–5. C. Cryosections o
CTNNB1 lacking phorphorylation at Ser37 or Thr41 (unph-CTNNB1). GFP immunostaining
(arrows) and myocardium. In mutant heart, CTNNB1 was unchanged in myocardium but dec
were downregulated in Wt1KO, consistent with decreased activity of this signaling pathwa
response to canonical Wnt signaling, in control and Wt1KO epicardium. *, Pb0.05. Scale barthis result indicates the abnormality of Raldh2 expression is speciﬁc to
Wt1KO and not a general property of mutants with perturbed epicardial
gene expression or epicardial EMT.
LikeWt1KO embryos, Raldh2 null embryos, treated with exogenous
retinoic acid to bypass early embryonic lethality, exhibitedmyocardial
hypoplasia and coronary vessel abnormalities (Lin et al., 2010),t1CreERT2/+ Rosa26mTmG hearts were pulsed with Tam for 12 h in vivo, then explanted
nd sFRP2 consistently blocked formation of GFP+ EPDCs. B. Differential expression of
re/+) FACS-puriﬁed epicardial cells. β-Catenin (Ctnnb1) was measured with unampliﬁed
f E13.5 heart stained for CTNNB1, CTNNB1 phosphorylated at Ser675 (ph-CTNNB1), or
marked epicardium and derivatives. In controls, CTNNB1 was expressed in epicardium
reased in epicardium (arrowheads). D. Downstream targets of Wnt/β-catenin signaling
y. Ampliﬁed RNA, n=4–5. E. Activity of the Batgal transgene, which expresses LacZ in
s: 10 μm (white), 100 μm (yellow).
AD
B C
Fig. 6. Abnormal Wnt5a expression in Wt1KO epicardium. A. Enrichment of Wnt5a in epicardium. n=3. *, Pb0.01. B. Downregulation of Wnt5a in Wt1KO epicardium. n=4–5.
*, P=0.03. C.Wnt5a regulates growth of compact myocardium. Bottom panels showmagniﬁcations of left ventricular free wall.Wnt5amutant hearts had thin compact myocardium
(blue arrows) and common atrioventricular canal (Δ). Bar=200 μm. D. WT1, RALDH2, and CTNNB1 immunoreactivity were unchanged in Wnt5a−/− epicardium. Arrowheads,
CTNNB1 in epicardial cells. Bar=10 μm.
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defective EMT in Wt1KO heart. To further address whether Raldh2
deﬁciency contributes to the defect in EMT observed in Wt1KO
embryos, we asked if bypassing Raldh2 deﬁciency by supplementation
with all-trans retinoic acid (ATRA) restored EMT inWt1KO heart. ATRA
treatment of pregnant mothers from E10.5 to E13.5 partially rescued
epicardial EMT (Fig. 7E). Wt1CreERT2-labeled EPDCs were present in
ATRA-treated Wt1KO myocardium, but were not observed in
untreated Wt1KO myocardium. However, the ATRA rescue was
incomplete, as less EPDCs were observed in ATRA-treated WT1KO
than in control embryos. These results indicate that abnormal retinoic
acid synthesis in Wt1KO epicardium contributes in part to deﬁcient
epicardial EMT in Wt1KO heart.
Discussion
Transitions between epithelial and mesenchymal cell types are
crucial for development and disease. Wt1 has been implicated in
regulating these transitions in multiple contexts, including kidney
development, heart development, and cancer. However, the mecha-
nisms by whichWt1 regulates these changes in cellular programs are
poorly understood. Here, we investigated the requirement of Wt1 for
epicardial EMT, using genetic tools to label, track, and isolate
epicardial cells. Using this unambiguous approach, we conﬁrmedthat epicardial EMT is strongly reduced in Wt1 knockout epicardium,
and we identiﬁed signaling pathways downstream of Wt1 that
mediate its effects on EMT and heart development (Fig. 8).
Recently, Wt1 was proposed to directly regulate Snail, Slug, and
E-cadherin in cardiac progenitors and in epicardium, so that Wt1 loss
of function putatively caused upregulation of E-cadherin and thereby
inhibited epicardial EMT (Martinez-Estrada et al., 2010).We could not
reproduce these results by immunostaining, nor did we ﬁnd
upregulation of E-cadherin transcripts in highly puriﬁed Wt1KO
epicardial cells by quantitative real time PCR, a more objective and
quantitative method. In fact, we did not detect epicardial E-cadherin
expression above background by either method in control or mutant
genotypes. While immunostaining and qRTPCR showed overall
reduction of Snail and Slug expression, this was due to reduced
number of subepicardial mesenchymal cells rather than reduced
expression within epicardial cells. Thus, reduced expression of SNAIL
and SLUG was a consequence of impaired EMT, rather than a
mechanism through which Wt1 loss of function abrogates EMT.
On the other hand, we found that Wt1 stimulated epicardial
Wnt/β-catenin signaling. A prior study of Ctnnb1 epicardial-restricted
loss of function demonstrated that β-catenin was required for
epicardial EMT (Zamora et al., 2007). Because β-catenin is essential
for canonical Wnt signaling, these studies suggested that canonical
Wnt signaling promotes epicardial EMT. However, β-catenin has
AC D
E
B
Fig. 7. Decreased epicardial expression of RALDH2 inWt1KO. A. Raldh2 transcript level, measured by qRTPCR, was decreased in FACS puriﬁed epicardial cells from E13.5 Wt1KO heart
compared to control. *, Pb0.05. n=4–5. B. In control embryos, epicardium expressed RALDH2 (blue arrowheads). The lining of the pericardium also expressed RALDH2 (arrows). In
Wt1KO embryos, epicardial RALDH2 expression was markedly downregulated (blue arrowheads), while expression in lung mesothelium (green arrowheads) and pericardium
(arrows) were unchanged. C. Markedly decreased RALDH2 immunoreactivity in Wt1KO heart. Co-staining for epicardium (GFP expressed from Wt1GFPCre; yellow arrowheads)
showed that loss of RALDH2 immunoreactivity was not due to lack of epicardium. White arrowheads, pericardium. D. RALDH2 expression was not signiﬁcantly altered in Ctnnb1EPI.
E. ATRA supplementation between E10.5 and E13.5 partially corrected deﬁcient epicardial EMT in Wt1KO heart. Arrow, EPDC. Arrowhead, epicardial cell. EPDCs were present in
ATRA-treated Wt1KO, but were absent in untreated Wt1KO (Fig. 2). Scale bars: 500 μm (black), 100 μm (white), 10 μm (yellow).
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themultiple functions of Ctnnb1 in epicardial EMTwas problematic. In
addition to conﬁrming the epicardial requirement of Ctnnb1 in
epicardial EMT, we provide two additional lines of evidence that the
role of epicardial canonical Wnt signaling in epicardial EMT. First, we
show epicardial activation of the Batgal transgene, a reporter of
canonical Wnt signaling (Maretto et al., 2003). Second, in explants weshow that epicardial EMT was strongly inhibited by two different
inhibitors of canonical Wnt signaling. Having established an impor-
tant role of Wnt/β-catenin signaling in epicardial EMT, we next
showed that Wt1 was a positive upstream regulator of this pathway.
Wt1 promoted epicardial expression of Ctnnb1 and Lef1, essential
components of the β-catenin signaling pathway. Moreover, down-
regulation of common targets of β-catenin signaling (Axin2, Ccnd1,
WT1
Raldh2 Wnt5a
LEF1, CTNNB1
Axin2, Ccnd1
Ccnd2
Epicardial EMT
Myocardial Growth
Fig. 8. WT1 regulates epicardial EMT and heart development through multiple signaling
pathways. WT1 promotes canonical Wnt/β-catenin signaling, as well as expression of
Wnt5a, a non-canonical Wnt ligand, and Raldh2, a key regulator of retinoic acid signaling.
430 A. von Gise et al. / Developmental Biology 356 (2011) 421–431and Ccnd2) and the Batgal reporter in epicardial cells suggested
decreased activity of this pathway in Wt1-deﬁcient embryos. WT1
was expressed normally in epicardial Ctnnb1 knockouts, positioning
β-catenin signaling genetically downstream of Wt1.
Downregulation of β-catenin signaling in Wt1KO epicardium likely
accounted for phenotypic similarity of epicardial loss of function of
Wt1 and Ctnnb1. Diminished EMT in embryos with compound
heterozygosity for Wt1 and Ctnnb1 suggested a genetic interaction,
consistent with Wt1 and Ctnnb1 function in the same pathway.
However, we were unable to assess embryos with epicardium-
restricted heterozygosity for Ctnnb1 alone because Cre-expressing
mice were obligate Wt1 heterozygotes. Wt1 heterozygosity may also
contribute to the defects observed in Ctnnb1ﬂ/ﬂ Wt1CreERT2/+ hearts,
although this limitation does not alter our conclusion that both Wt1
and Ctnnb1 function in a pathway essential for epicardial EMT.
Wt1 has been reported to regulate canonical Wnt signaling in both
kidney development and cancer (Kim et al., 2009; Li et al., 2004).
Interestingly, as we saw in epicardium,Wt1 also stimulated expression
of Lef1 in models of kidney development (Kim et al., 2009). In this
systemWT1was found to occupy LEF1 regulatory elements, suggesting
direct transcriptional regulation. However, Wt1 has largely been
described to repress canonical Wnt signaling in mesenchymal cells in
kidney development and cancer (Kim et al., 2009; Li et al., 2004), while
our data suggests that Wt1 stimulates Wnt/β-catenin signaling in
epicardium. The differing roles of Wt1 in these systems may reﬂect
differing functions in epithelial cells such as epicardium, where Wt1
promotes epithelial to mesenchymal transition, compared to mesen-
chymal cells, such as kidneymetanephric tissue andWilm's tumor cells,
whereWt1 promotes mesenchymal to epithelial transition.
While impaired β-catenin signaling contributed to features of
epicardial Wt1 loss of function, attempts to rescue Wt1KO mutants by
lithium chloride-induced activation of canonical Wnt signaling (Tian
et al., 2010) were unsuccessful (data not shown). In part, this may have
been due to toxicity of this treatment at the later gestational stage
necessary for our study. This result may also have been due to Wt1
regulation of essential epicardial functions that are independent of
β-catenin.
In addition to regulating epicardial β-catenin signaling, Wt1 also
regulated Wnt5a and retinoic acid signaling pathways. Wnt5a, a key
regulator of non-canonical Wnt signaling, was enriched in epicardi-
um, andWnt5awas downregulated in Wt1KO epicardium. Like Wt1KO
hearts, Wnt5a−/− hearts had marked thinning of the compact
myocardium, suggesting that impaired epicardial expression of
Wnt5a contributes to myocardial thinning seen in Wt1KO heart.However, epicardial-restricted inactivation of Wnt5a will be required
to conﬁrm the epicardial role of Wnt5a.
Retinoic acid signaling was another Wt1-dependent, β-catenin
independent signaling pathway. This ﬁnding was corroborated by the
recent report by Guadix et al. (2011) that Wt1 regulates epicardial
Raldh2 expression. Retinoic acid signals are essential for cardiac
morphogenesis and myocardial growth (Chen et al., 2002; Hochgreb
et al., 2003; Lin et al., 2010; Stuckmann et al., 2003). Cardiac
expression of the enzyme RALDH2, which catalyzes an essential step
in retinoic acid synthesis, is restricted to the epicardium (Moss et al.,
1998), and Raldh2 loss of function resulted in abnormalities of cardiac
growth and coronary development similar to those inWT1KO embryos
(Lin et al., 2010). Deﬁcient epicardial synthesis of retinoic acid
contributes to the epicardial EMT defect of WT1KO embryos, since the
EMT defect was partially rescued by retinoic acid replacement.
However, the rescue was incomplete and epicardial derivatives
formed by EMT were present in Raldh2−/− heart (Lin et al., 2010),
suggesting that EMT does not absolutely require Raldh2. Retinoic acid
also regulates differentiation of epicardium-derived cells (Azambuja
et al., 2010), and therefore the contribution of RALDH2 deﬁciency to
the Wt1KO phenotype is multifactorial.
Interestingly, mesothelial requirement for Wt1 differed between
subtypes of mesothelium. For instance,Wt1marks mesenchymal cells
derived from both epicardium (Wilm et al., 2005; Zhou et al., 2008;
this study) and gut mesothelium (Wilm et al., 2005). However, Wt1
was dispensable for gut mesothelium EMT, but was required for
normal epicardium EMT. Wt1 regulation of Raldh2 also differed
between mesothelial subtypes: Wt1 was required for Raldh2 expres-
sion in epicardium (this study and Guadix et al., 2011) and liver
mesothelium (Ijpenberg et al., 2007), but was dispensible for Raldh2
expression in lung mesothelium. It will be interesting to determine
the mechanisms responsible for the differing roles of Wt1 in these
various types of mesothelium.
Wt1 loss of function impaired formation of the coronary vascular
plexus (this study and Martinez-Estrada et al., 2010; Moore et al.,
1999). Wt1-lineage cells make little cellular contribution to the
coronary endothelium (Wilm et al., 2005; Zhou et al., 2008),
indicating that Wt1 acts cell non-autonomously. Epicardium overlies
the nascent coronary vascular plexus, and we recently showed that
fetal epicardium is a rich source of angiogenic factors (Zhou et al.,
2011). In Wt1 loss of function, epicardial expression of Vegfa and
Angpt1 were signiﬁcantly diminished, indicating that abnormal
expression of epicardial angiogenic factors contributes to coronary
vascular defects seen in these mutant hearts.
Cardiac injury reactivates a fetal epicardial program that includes
re-expression ofWt1, epicardial expansion via EMT, and upregulation
of Raldh2 (Zhou et al., 2011). Reactivation of WT1 and reawakening of
fetal epicardial properties likely contribute to the myocardial injury
response. Thus, understanding of Wt1 regulation of epicardial
function during development may improve our understanding of
mechanisms that govern myocardial injury responses and may
translate into strategies to therapeutically modulate these responses
to improve outcome in adult heart disease.
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